MENU
APGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Apogee Therapeutics (APGE) Earnings Date & Reports

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need... Show more

A.I. Advisor
published Earnings

APGE is expected to report earnings to fall 50.85% to -57 cents per share on May 19

Apogee Therapeutics APGE Stock Earnings Reports
Q1'25
Est.
$-0.58
Q4'24
Missed
by $0.56
Q3'24
Missed
by $0.30
Q2'24
Missed
by $0.08
Q1'24
Missed
by $0.15
The last earnings report on March 03 showed earnings per share of -117 cents, missing the estimate of -62 cents. With 717.04K shares outstanding, the current market capitalization sits at 2.03B.
View a ticker or compare two or three
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com